Submitted by Anonymous (not verified) on 19 July 2024 - 11:50
Opinion/decision on a Paediatric investigation plan (PIP): Dovato, lamivudine,dolutegravir, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0121/2023
Source: